TABLE 1.
The effect of different treatment interventions on selected haematological parameters at different time intervals.
| Groups | Baseline mean (SD) | Day 30 mean (SD) | Day 60 mean (SD) | p‐values * (between baseline and day 60) | p‐value * (between group) |
|---|---|---|---|---|---|
| Erythrocyte count (1012/L) | |||||
| ARE | 7.55 (0.60) | 7.41 (0.58) | 8.31 (0.41) | <0.001 | <0.001 |
| Placebo | 7.31 (0.41) | 6.72 (0.47) | 6.63 (0.89) | 0.013 | |
| Leucocyte count (109/L) | |||||
| ARE | 20.42 (3.31) | 20.39 (2.36) | 16.14 (3.60) | 0.05 | 0.007 |
| Placebo | 20.17 (4.17) | 20.36 (1.86) | 20.95 (4.32) | 0.226 | |
| Haemoglobin (g/dL) | |||||
| ARE | 10.39 (1.21) | 12.01 (1.01) | 12.15 (1.00) | <0.001 | <0.001 |
| Placebo | 10.35 (1.03) | 10.42 (0.91) | 9.79 (0.70) | 0.066 | |
Abbreviation: ARE, ashwagandha root extract.
*
Statistically significant. p < 0.05 is considered statistically significant.